Market Overview

Impax Laboratories Up On FDA Approval (IPXL)

Impax Laboratories, Inc. (NASDAQ: IPXL) is up around 1% in early Wednesday trading after the company received final FDA approval today for generic Doryx 75 and 100mg tablets.

At last check, shares of Impax were up 23 cents to $20.73, a gain of 1.1%.

Posted-In: News FDA

 

Related Articles (IPXL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters